Reperfusion Therapy Safety in Pregnancy and Postpartum Stroke

Ischemic stroke occurring during pregnancy or the postpartum period is a rare but life-threatening event. Historically, clinicians have been cautious about using advanced interventions in this population. However, a new meta-analysis highlights the safety of reperfusion therapy in pregnancy. This study provides much-needed clarity for emergency medicine and neurology specialists managing these critical cases.

The Efficacy of Reperfusion Therapy in Pregnancy

The research team performed a systematic review and single-arm meta-analysis involving 275 patients. They evaluated the clinical use of intravenous thrombolysis (IVT) and mechanical thrombectomy (MT). Specifically, the findings indicated that 85% of women achieved functional recovery at the three-month mark. This high success rate suggests that the effectiveness of these treatments matches the results seen in the general population. Furthermore, maternal in-hospital mortality was remarkably low, at approximately 0% across the included studies.

Maternal Safety and Fetal Health Outcomes

Safety concerns often center on the risk of bleeding. The study observed that the rate of symptomatic intracerebral hemorrhage (sICH) was only 3%. This figure is comparable to non-pregnant stroke cohorts. Moreover, the health of the fetus remained a primary concern. The data showed that 78% of pregnancies resulted in good fetal outcomes. Consequently, these findings reinforce the idea that pregnancy should not automatically disqualify a patient from life-saving stroke care. European Stroke Organisation guidelines already recommend individualized decision-making for these patients.

Individualized Decisions in Acute Stroke Care

Multidisciplinary teams should collaborate quickly when a pregnant patient presents with stroke symptoms. Because the risk of disability is high, the benefits of restoring blood flow often outweigh the potential risks of thrombolysis or thrombectomy. Therefore, physicians should treat eligible patients based on their specific clinical profile rather than following broad exclusion criteria.

FAQs

Is intravenous thrombolysis safe during the postpartum period?

Yes, research indicates that thrombolysis is safe for postpartum women. Guidelines suggest that the postpartum period should not be a contraindication for IVT or MT when the patient meets standard eligibility criteria.

What are the risks of reperfusion therapy to the fetus?

The risk of fetal harm appears low. Current data demonstrate favorable fetal outcomes in nearly 80% of cases, with no direct treatment-related fetal mortality reported in large systematic reviews.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Tamara Alves Carretta L et al. Reperfusion therapy in pregnant and postpartum women after ischemic stroke: a systematic review and single-arm meta-analysis. Neurol Res. 2026 Apr 11. doi: 10.1080/01616412.2026.2657383. PMID: 41964369.

Calisaya-Madariaga IG et al. Safety and clinical outcomes of mechanical thrombectomy for acute stroke in pregnant patients: a systematic review. J Neurointerv Surg. 2026 Jan 22. doi: 10.1136/jnis-2025-024431. PMID: 41571461.

Kremer C et al. European Stroke Organisation guidelines on stroke in women: Management of menopause, pregnancy and postpartum. Eur Stroke J. 2022 Jun;7(2):I-XIX. doi: 10.1177/23969873221078696.